COVID-19 severity scoring systems in radiological imaging : a review by unknown
e361
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0  
International (CC BY-NC-ND 4.0). License (https://creativecommons.org/licenses/by-nc-nd/4.0/).  






COVID-19 severity scoring systems in radiological imaging – a review
Piotr G. WasilewskiA,E,F, Bartosz MrukE,F, Samuel MazurE, Gabriela Półtorak-SzymczakF, Katarzyna SklindaE,F,  
Jerzy WaleckiA,E 
Department of Radiology, Medical Centre of Postgraduate Education, Warsaw, Poland
Department of Diagnostic Radiology, Central Clinical Hospital of the Ministry of the Interior in Warsaw, Poland
Abstract
The current reference standard to make a definitive diagnosis of SARS-CoV-2 infection is the reverse transcription- 
polymerase chain reaction assay (rt-PCR). However, radiological imaging plays a crucial role in evaluating the course 
of COVID-19 and in choosing proper management of infected patients. Chest X-ray (CXR) is generally considered not 
to be sensitive for the detection of pulmonary abnormalities in the early stage of the disease. However, in the emergency 
setting CXR can be a useful diagnostic tool for monitoring the rapid progression of lung involvement in COVID-19, 
especially in patients admitted to intensive care units. The rapid course of SARS-CoV-2 infection and the severity and 
progression of lung aberrations require a method of radiological evaluation to implement and manage the appropriate 
treatment for infected patients. Computed tomography (CT) imaging is considered to be the most effective method for 
the detection of lung abnormalities, especially in the early stage of the disease. Moreover, serial chest CT imaging with 
different time intervals is also effective in estimating the evolution of the disease from initial diagnosis to discharge 
from hospital. Despite having low specificity in distinguishing abnormalities in viral infections, the high sensitivity of 
CT makes this method ideal for assessing the severity of the disease in patients with confirmed COVID-19.
In this review, we present and discuss currently available scales that can be used to assess the severity of lung involvement 
in COVID-19 patients in everyday work, both for CXR and CT imaging.
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Introduction
Since the first infections were noticed in December 2019 
in Wuhan, China [1], SARS-CoV-2 has spread to the en-
tire world. The World Health Organisation (WHO) has 
designated the ongoing pandemic of COVID-19 a Pub-
lic Health Emergency of International Concern [2,3]. 
At the moment, the reference standard to make a definitive 
diagnosis of SARS-CoV-2 infection is the reverse trans-
cription-polymerase chain reaction assay (rt-PCR) [4]. 
However, radiological imaging plays a crucial role in evalu-
ating the course of COVID-19 and in choosing the proper 
management of infected patients.
Chest X-ray (CXR) is generally considered not to be sen-
sitive for the detection of pulmonary abnormalities in the 
early stage of the disease [5,6]. However, in the emergency 
setting CXR can be a useful diagnostic tool for monitoring 
the rapid progression of lung involvement in COVID-19, 
especially in patients admitted to intensive care units [7]. 
Computed tomography (CT) imaging is considered to 
be the most effective method for detection of lung abnor-
malities, especially in the early stage of the disease [5,8]. 
Moreover, serial chest CT imaging with different time inter-
vals is also effective in estimating the evolution of the disease 
from initial diagnosis to discharge from hospital [8,9].
However, the results of radiological examinations can 
vary between radiologists. This bias is particularly pres-
ent in chest imaging. In order to standardise the results of 
radiological descriptions and turn them into a measurable 
outcome, there is a need for an objective tool for radiolo-
gists to follow. An algorithm in the form of a medical scale 
may play the role of such a tool.
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In this review, we present and discuss currently avail-
able scoring systems that can be used to assess the severity 
of lung involvement in COVID-19 patients in everyday 
work, both for CXR and CT imaging.
Chest X-ray imaging
Although the CT imaging is the best method of assessing 
the specific abnormalities of the disease and its evolution 
in time, the increasing number of hospitalised patients 
and the indisputable increase of radiological examina-
tions make the constant use of chest CT scans difficult to 
sustain.
The rapid course of SARS-CoV-2 infection and the se-
verity and progression of lung aberrations require a meth-
od of radiological evaluation to implement and manage 
the appropriate treatment for infected patients.
While the CXR examination has a very low sensitiv-
ity for the detection of pulmonary abnormalities in the 
early-stage disease, it can be widely used for monitoring 
the progression and later stages of COVID-19, especially 
in patients in a critical state.
Here we present scoring methods used to determine 
the intensity of the disease in CXR images.
SARI chest X-ray severity scoring system
This system was presented by Taylor et al. in “BMC Medi-
cal Imaging” in 2015 [10]. The authors intended to de-
velop and validate a CXR scoring system that could be 
used by non-radiologist clinicians to assess patients with 
acute respiratory diseases. 
It was created in the pre-COVID era, and its goal was 
to simplify the clinical grading of CXR reports into five 
different severity categories in hospitalised patients with 
confirmed acute respiratory infection.
CXR findings were categorised as: 1 – normal; 2 – patchy 
atelectasis and/or hyperinflation and/or bronchial wall 
thickening; 3 – focal consolidation; 4 – multifocal consoli-
dation; and 5 – diffuse alveolar changes (Figure 1).
It was reported only once by Yoon in Southern Korea 
[11] that this scoring system was used to quantify the pul-
monary involvement in COVID-19 patients.
RALE classification
This is a system presented by Wong et al., which was 
published in “Radiology” in March 2020 [12]. The aim of 
this study was to describe the course and severity of CXR 
findings in COVID-19 and correlate them with rt-PCR 
results.
The authors adapted and simplified the Radiographic 
Assessment of Lung (O)Edema (RALE) score proposed by 
Warren et al. in 2018 [13].
Each lung was assessed individually, and depending 
on the extent of involvement by consolidation or ground-
glass opacity a score of 0 to 4 points was given (0 – no 
involvement; 1 – less than 25%; 2 – 25% to 50%; 3 – 50% 
to 75%; 4 more than 75% involvement). The overall score 
was the sum of points from both lungs (Figure 2).
This study included 64 patients (26 men, 38 women, 
mean age 56 ± 19 years). Chest X-ray findings in COVID-19 
patients frequently showed bilateral lower zone consolida-
tion, which peaked 10-12 days after symptom onset; the 
highest recorded score was 8 and the median CXR severity 
score was 3.
Out of the 20 patients who had normal baseline CXRs, 
seven developed abnormalities on follow-up CXR.
Chest X-ray score
This is the only method to date of assessing CXR, de-
signed specifically for patients with confirmed COVID-19. 
It was proposed by Borghesi and Maroldi in March 
2020 [7].
This CXR scoring system includes two steps of imaging 
analysis. The first step is to divide each lung into three zones 
on frontal chest projection (PA or AP), marked as letters A, 
B, and C for the right lung and D, E, and F for the left lung.
The letters divide lungs into three levels: upper level 
(A and D) – above the inferior wall of the aortic arch; 
middle level (B and E) – below the inferior wall of the 
aortic arch and above the inferior wall of the right infe-
rior pulmonary vein (the hilar structures); and lower level 
(C and F) – below the inferior wall of the right inferior 
pulmonary vein (the lung bases) (Figure 3).
The second step is to assign a score (from 0 to 3 points) 
to each zone based on the detected lung abnormalities: 
0 – no lung abnormalities; 1 – interstitial infiltrates; 
2 – interstitial and alveolar infiltrates (interstitial pre-
dominance); and 3 – interstitial and alveolar infiltrates 
(alveolar predominance). The overall score is the sum of 
the points from all the zones with a range from 0 to 18 
(Figures 4 and 5).
The overall CXR score as well as the partial score of 
each zone can be seen at the end of the report.
This study included 100 patients hospitalized patients 
with confirmed SARS-CoV-2 infection. The reports 
ranged from 0 to 16 with a median of 6.5. The CXR score 
was significantly higher in patients who died than in those 
who were discharged from the hospital (p ≤ 0.002).
Computed tomography imaging
CT imaging is the most effective method for detecting 
lung abnormalities in patients with COVID-19. In the 
early months of the ongoing pandemic CT scans were 
considered as the primary tool for COVID-19 detection 
in epidemic areas [14] and were even used for diagnosing 
patients with this disease. 
In these cases, the exposure to side effects of perform-
ing the scans had to be diminished as much as possible; 
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therefore, the protocol for CT in monitoring the course of 
the disease was limited to performing a native phase with 
a small dosage of radiation with no contrast administered.
However, despite having very high sensitivity (up to 
90%) [15], CT has very low specificity, and typical abnor-
malities cannot be distinguished from other viral infections, 
such as pneumonia in the course of influenza or adenovirus 
infections. This excludes tomography from being used as 
a tool of definitive diagnosis of SARS-CoV-2 infection.
Nevertheless, the high sensitivity of CT makes this 
method ideal for assessing the severity of the disease in 
patients with confirmed COVID-19.
In order to properly standardise and quantify the 
radiological examinations, physicians all over the world 
implemented different algorithms of evaluating the sever-
ity of lung abnormalities. Below, we present three most 
promising scales to determine the severity of pulmonary 
involvement of COVID-19.
Figure 2. Chest X-ray image of a COVID-19-positive patient with lungs 
assessed in RALE classification at 4 points. Both lungs are assessed indi-
vidually - right lung was evaluated at 1 point and left lung at 3 points. 
The overall RALE score was 4 points
Figure 1. Chest X-ray image of a COVID-19-positive patient with lungs 
assessed in SARI severity scoring system at 5 points. The arrow shows diffuse 
alveolar changes
Figure 4. Chest X-ray image of a COVID-19-positive patient with lungs 
assessed in chest X-ray sore at 0 points
Figure 3. Normal chest X-ray image with division of lungs into six levels 
in SXR score
Figure 5. Chest X-ray image of a COVID-19-positive patient with lungs 
assessed in chest X-ray sore at 8 points
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Figure 6. Computed tomography scans of a COVID-19-positive patient in axial projection. Lungs were assessed in modified total severity scoring system 
(mTSS) at 6 points. The main features of lung involvement are regions of ground glass opacity; therefore, the overall mTSS score is 6A
Figure 7. Computed tomography scans of a COVID-19-positive patient in sagittal projection. Lungs were assessed in modified total severity scoring system 
(mTSS) at 6A
Chest computed tomography severity score
This method was proposed by Yang et al. and was pub-
lished in “Radiology” in March 2020 [16]. It was created 
to help assess COVID-19 burden on the initial scan ob-
tained at admission and provide an objective approach 
to identify patients in need of admission to hospital. 
The score (CT-SS) is an adaptation of a method previously 
used during the SARS epidemic of 2005 [17].
This scale uses lung opacification as an equivalent for 
extension of the disease in the lungs. 
In this study, the 18 segments of both lungs were di-
vided into 20 regions, in which the posterior apical seg-
ment of the left upper lobe was subdivided into apical 
and posterior segmental regions, while the antero-medial 
basal segment of the left lower lobe was subdivided into 
anterior and basal segmental regions.
Then, the lung opacities in all of the 20 lung regions 
were subjectively evaluated on chest CT. Each region was 
scored 0, 1, or 2 points depending on the parenchymal 
opacification involved: 0%, 1-50%, or 51-100%, respec-
tively.
The overall CT severity score was defined as the sum 
of the points scored in each of the 20 lung segment re-
gions, which ranges from 0 to 40 points.
In the study, the authors included 102 patients with 
confirmed SARS-CoV-2 infection in rt-PCR (53 men and 
49 women, 15-79 years old, 84 cases with mild and 18 
cases with severe disease)
The optimal CT-SS threshold for identifying severe 
COVID-19 was 19.5 points, with 83.3% sensitivity and 
94% specificity.
The inter-observer ICC for CT-SS was found to be ex-
cellent, with median ICC 0.925 and mean ICC 0.936 for 
102 patients.
Total severity score
This method was presented by Kunwei et al. and was 
published in “European Radiology” in March 2020 [18]. 
The main objective of the study was to explore the rela-
tionship between the imaging manifestations and clinical 
classification of COVID-19.
The authors of the study assessed each of the five lobes 
of the both lungs for the presence of inflammatory abnor-
malities, including the presence of ground-glass opacities, 
mixed ground-glass opacities, or consolidation.
Each lobe could be awarded 0 to 4 points, depending 
on the percentage of the involved lobe: 0 (0%), 1 (1-25%), 
2 (26-50%), 3 (51-75%), or 4 (76-100%) (Figures 6-11).
The total severity score (TSS) was then reached by 
summing the points from each of the five lobes. The TSS 
cut-off for identifying severe-critical type of 7.5 with 
82.6% sensitivity and 100% specificity.
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Figure 8. Computed tomography scans of a COVID-19-positive patient in coronal projection. Lungs were assessed in modified total severity scoring system 
(mTSS) at 6A
Figure 9. Computed tomography scans of a COVID-19-positive patient in axial projection. Lungs were assessed in modified total severity scoring system 
(mTSS) at 18 points. The main features of lung involvement are consolidations; therefore, the overall mTSS score is 18C
Figure 10. Computed tomography scans of a COVID-19-positive patient in sagittal projection. Lungs were assessed in modified total severity scoring system 
(mTSS) at 18C
Figure 11. Computed tomography scans of a COVID-19-positive patient in coronal projection. Lungs were assessed in modified total severity scoring system 
(mTSS) at 18C
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In this study, the authors included 78 patients with 
confirmed SARS-CoV-2 infection in rt-PCR, divided into 
four groups: minimal, common, severe, and critical dis-
ease (24 patients with minimal, 46 with common, six with 
severe, and two with critical disease). All CT images were 
reviewed by two radiologists with five and three years of 
experience in radiology. 
The consistency of results of this method from two 
readers showed good repeatability with ICC – equal to 
0.976 (95% confidence interval 0.962-0.985).
Chest computed tomography score
This method was presented by Li et al. and was published 
in Investigative Radiology in March 2020 [19]. The au-
thors intended to find another objective method to iden-
tify significant radiological differences between severe and 
milder cases of COVID-19. 
Similarly to the TSS scale, in this study both lungs 
were divided into five lobes, and each lobe was assessed 
individually. The abnormalities that were considered sig-
nificant for the disease included the following: ground-
glass opacity, consolidation, nodule, reticulation, inter-
lobular septal thickening, crazy-paving pattern, linear 
opacities, subpleural curvilinear line, bronchial wall 
thickening, lymph node enlargement, pleural effusion, 
and pericardial effusion.
Each lobe could be awarded a CT score from 0 to 5, 
depending on the percentage of the involved lobe: score 
0 – 0% involvement; score 1 – less than 5% involvement; 
score 2 – 5% to 25% involvement; score 3 – 26% to 49% 
involvement; score 4 – 50% to 75% involvement; score 
5 – greater than 75% involvement.
The overall CT score was the sum of the points from 
each lobe and ranges from 0 to 25 pints. The cut-off value 
for identifying severe cases of COCID-19 of CT score was 
7, with the sensitivity and specificity of 80.0% and 82.8%, 
respectively. 
All the scans were assessed by two chest radiologists 
with 10 and 8 years of experience, who were blinded to 
the clinical data evaluated the CT findings in consensus. 
Conclusions
The pandemic of SARS-CoV-2 continues to grow. Each 
day hundreds of thousands of newly diagnosed patients 
appear, not only blocking the treatment capability of hos-
pitals and intensive care units, but also the diagnostic ca-
pacity of medical facilities. 
There is a noticeable need for proper radiological as-
sessment of patients freshly diagnosed with COVID-19 as 
well as the ones with ongoing disease. Objective evaluation 
of the course of the infection gives the possibility to choose 
the correct treatment and to classify the infected properly. 
There are only a few tools that can be used to turn 
radiological reports into measurable results, but they are 
very promising. Quantifying the radiological data is cru-
cial for standardisation of the outcome.
Radiology is one of the fastest developing medical 
fields. Its connection to modern technology is the reason 
why industry can help to set a milestone in diagnostics. 
One such promising branch of new technology in radi-
ology is artificial intelligence, which is useful in finding 
patterns of specific diseases.
Without standardised and quantified results of chest 
imaging, there is no possibility to create neural networks 
for deep learning programs to help radiologist assess a ris-
ing number of examinations as well as to help clinicians 
acquire results much faster, in order to rapidly apply ap-
propriate treatment. 
Implementing and using scoring systems in our radi-
ology departments is the right step to make. 
Which method should we choose, then? Each of them 
has its advantages but also some imperfections.
There are still no adequate systems for evaluating the 
CXR images of COVID-positive patients. 
The SARI CXR Severity Scoring System [10] was de-
signed for clinicians in the pre-COVID era and is subjec-
tive for a reporting physician. In our opinion, it has a very 
limited use for tracking the course of the disease.
Although the RALE classification was designed in 
2018 [12], its modified version has been reported to be 
used in ongoing pandemic. It has been proven to success-
fully identify the changes in the course of infection, even 
though the reporting radiologist assesses the entire lungs 
as a whole, without dividing them into sectors. 
The only method invented especially for assessing the 
evolution of SARS-CoV-2 infection is the CXR Scoring 
System of Andrea Borghesi and Roberto Maroldi [7]. 
More research is needed to recognise this method as 
a standard, but the accuracy and facility of assessment as 
well as the initial results are very promising.
In the Table 1 we list all the above-mentioned CXR 
scoring systems and compare their features.
The main benefit of CT-SS, proposed by Ran Yang 
[16], is the high accuracy of assessing the abnormalities. 
However, the number of regions needed to be processed 
by a radiologist may cause difficulties during evaluation.
In comparison to the Chest CT Severity Score, the To-
tal Severity Score presented by Kunwei et al. [18] requires 
a smaller number of regions to be assessed; it includes, 
however, more intervals to consider during evaluation.
Chest CT Scoring System of Li et al. [19] has a similar 
assessment algorithm to the TSS; however, the number of 
intervals for evaluation is even greater.
According to the authors of the CT-SS and TSS scor-
ing systems, the inter-observer consistency in reading the 
radiological studies is excellent. 
It is worth mentioning that in all cited systems the ra-
diological studies were examined by at least two physicians.
Computed tomography is the best imaging method 
not only for assessing the involvement of the lungs, but it 
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is also the best and the fastest method for evaluating the 
character of abnormalities.
In our department, we found the TSS system to be an 
optimal scoring method for diagnosticians to follow.
The character of abnormalities is not taken into ac-
count in the presented diagnostic algorithm. The abun-
dance of specific patterns of pulmonary involvement may 
imply the time point in the course of the infection. The 
intensity of these abnormalities may not only be helpful in 
evaluating the stage of COVID-19, but it can also suggest 
the severity of the disease.
Therefore, we decided to modify the Total Severity 
Score (mTSS) scale and to include additional qualitative 
features of lung involvement: A – ground glass opacity, 
B – crazy-paving pattern, C – consolidations, X – charac-
ter other than enlisted. 
The overall result is the sum of the points from each of 
the five lobes and a letter that represents the most abun-
dant abnormality in both lungs (e.g. 15C – the majority of 
the abnormalities were consolidations).
In Table 2 we enlist all the above-mentioned CT scor-
ing systems and compare their features.
Although there are insufficient data to definitively 
take one of the sides, the golden balance to aim at when it 
comes to choosing and implementing a specific method 
in radiology departments is to produce a clear scoring al-
gorithm, obtaining a definitive cut-off threshold for iden-
tifying severe COVID-19 cases and reaching good repeat-
ability between specialists.
Such inter-observer consistency is crucial in finding 
a standard scoring algorithm. The top feature of such 
a system should be the production of as many objective 
and repeatable results as possible, in order to obtain data 
in quantified form.
The future of radiology follows technological advance-
ment. We started gathering data in quantified form not 
only to create the most reliable and comparable results to 
find the optimal treatment, but also to allow technological 
industry create new tools that will eventually elevate the 
level of modern medicine.
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Lung regions to consider 20 segmental
regions
5 lobes 5 lobes 5 lobes
Number of intervals 3 5 6 5
Level of involved organ 
assessment
Yes Yes Yes Yes
Character of abnormalities 
assessment
No No No Yes
Sensitivity 83.3% 82.6% 80% No data
Specificity 94% 100% 82.8% No data
Mean inter-observer ICC 0.936 0.976 No data No data
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